Search tool

Interventions to prevent opioid-related death by intended aim and evidence of benefit

Notes: Interventions where there is evidence of benefit and where we can have a high or reasonable confidence in the available evidence, are highlighted in a bolder frame. Much of the current...

Annex tables to the European Drug Report 2023

The data tables here are part of the annex of the European Drug Report 2023 . National data presented here are mainly a subset of data available in the Statistical Bulletin 2023...

#WorldHepatitisDay — EMCDDA practical resources to help European countries beat viral hepatitis

Every year, on 28 July, the World Health Organization (WHO) and partners commemorate World Hepatitis Day to increase awareness and understanding of viral hepatitis and the diseases it causes. The focus of...

Emergency vehicle driving fast on a blurred street

New EMCDDA miniguide on responding to opioid-related deaths highlights approaches and evidence that can help save lives

Health and social responses to opioid-related deaths are explored in a new EMCDDA miniguide launched today. The resource is the ninth in a series of miniguides, making up the agency’s latest overview...

European Drug Report

European Drug Report 2019: Trends and Developments

The Trends and Developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as drug policy and responses. Together with...

Chart showing national estimates of annual prevalence rate of high-risk opioid use: selected trends and most recent data

Infographic: national estimates of annual prevalence rate of high-risk opioid use: selected trends and most recent data

Technical reports

An overview of the problem drug use (PDU) key indicator

This document gives an overview of the problem drug use (PDU) indicator, one of five key epidemiological indicators used by the EMCDDA for the collection and interpretaion of harmonised, good quality data...